LON:DNLDiurnal Group Share Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Diurnal Group PLC Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add GBX 30 -0.50 (-1.64 %) (As of 07/7/2020 06:17 AM ET) Add Compare Share Today's Range 30Now: GBX 30▼ 3150-Day Range 30MA: GBX 34.17▼ 3952-Week Range 19Now: GBX 30▼ 47Volume159,376 shsAverage Volume7,428 shsMarket Capitalization£36.49 millionP/E RatioN/ADividend YieldN/ABetaN/A ProfileAdvanced ChartCompetitorsEarningsInsider TradesHeadlines Diurnal Group plc operates as a specialty pharma company. The company develops hormone therapeutics for the treatment of chronic endocrine conditions, including congenital adrenal hyperplasia, adrenal insufficiency, hypogonadism, and hypothyroidism. Its product pipeline includes Infacort for use in children suffering from adrenal insufficiency; and Chronocort, which completed Phase III clinical trials targeting congenital adrenal hyperplasia in adult patients, as well as adrenal insufficiency. The company's early stage pipeline products comprise Native Oral Testosterone, a replacement treatment for patients suffering from hypogonadism; siRNA, a short interfering RNA oligonucleotide therapy for patients suffering from adrenocorticotropin-dependent Cushing's syndrome; and T3 modified, a modified-release preparation of T3 (levothyroxine) hormone for patients suffering from hypothyroidism. Diurnal Group plc was incorporated in 2015 and is headquartered in Cardiff, the United Kingdom.Read More Beat the Market (BTM) Rank™ 0.0 Analyst's Opinion Consensus RatingThere is not enough analysis data for Diurnal Group. Previous Next 2.8 Community Rank Outperform VotesDiurnal Group has received 197 “outperform” votes. (Add your “outperform” vote.)Underperform VotesDiurnal Group has received 154 “underperform” votes. (Add your “underperform” vote.)Community SentimentDiurnal Group has received 56.13% “outperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about Diurnal Group and other stocks. Vote “Outperform” if you believe DNL will outperform the S&P 500 over the long term. Vote “Underperform” if you believe DNL will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldDiurnal Group does not currently pay a dividend.Dividend GrowthDiurnal Group does not have a long track record of dividend growth. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Diurnal Group insiders have not sold or bought any company stock. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for Diurnal Group are expected to grow in the coming year, from GBX (27.06) to GBX 0 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Diurnal Group is -2.78, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Diurnal Group is -2.78, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioDiurnal Group has a P/B Ratio of 3.49. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next Analyst Opinion: 0.0Community Rank: 2.8Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -Overall Beat the Market Rank™0.69 out of 5 stars Industry, Sector and Symbol Stock Exchange LON Industry Drug Manufacturers - Specialty & Generic Sub-IndustryN/A SectorMedical Current SymbolLON:DNL Previous Symbol CUSIPN/A CIKN/A Webwww.diurnal.co.uk Phone+44-29-20682069Debt Debt-to-Equity Ratio0.77 Current Ratio4.46 Quick Ratio3.80Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual Sales£2.01 million Price / Sales18.20 Cash FlowGBX 5.31 per share Price / Cash Flow5.65 Book ValueGBX 8.60 per share Price / Book3.49Profitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous Employees23 Outstanding Shares121,633,000Market Cap£36.49 million Next Earnings DateN/A OptionableNot Optionable LSE:DNL Rates by TradingView Receive DNL News and Ratings via Email Sign-up to receive the latest news and ratings for DNL and its competitors with MarketBeat's FREE daily newsletter. Diurnal Group (LON:DNL) Frequently Asked Questions How has Diurnal Group's stock been impacted by COVID-19 (Coronavirus)? Diurnal Group's stock was trading at GBX 34 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, DNL shares have decreased by 11.8% and is now trading at GBX 30. View which stocks have been most impacted by Coronavirus. How were Diurnal Group's earnings last quarter? Diurnal Group PLC (LON:DNL) released its quarterly earnings results on Tuesday, February, 11th. The company reported ($4.70) EPS for the quarter. View Diurnal Group's earnings history. Has Diurnal Group been receiving favorable news coverage? News stories about DNL stock have trended negative on Tuesday, InfoTrie Sentiment reports. The research firm rates the sentiment of media coverage by analyzing more than six thousand blog and news sources in real-time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Diurnal Group earned a media sentiment score of -2.1 on InfoTrie's scale. They also assigned media coverage about the company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an effect on the company's share price in the near future. View the latest news about Diurnal Group. Who are some of Diurnal Group's key competitors? Some companies that are related to Diurnal Group include ESSA Pharma (EPI), Probiotec (PBP), Green Organic Dutchman (TGOD), Shield Therapeutics (STX), WeedMD (WMD), cbdMD (YCBD), Althea Group (AGH), Supreme Cannabis (FIRE), Delta 9 Cannabis (NINE), Flowr (FLWR), Venture Life Group (VLG), Biosyent (RX), Acerus Pharmaceuticals (ASP), MMJ Group (MMJ) and Auscann Group (AC8). View all competitors. What other stocks do shareholders of Diurnal Group own? Based on aggregate information from My MarketBeat watchlists, some companies that other Diurnal Group investors own include Allena Pharmaceuticals (ALNA), Abercrombie & Fitch (ANF), Ampliphi Biosciences (APHB), Cerecor (CERC), Revolution Lighting Technologies (RVLT), Spero Therapeutics (SPRO), SRC Energy (SRCI), Arbutus Biopharma (ABUS), Aurora Cannabis (ACBFF) and AcelRx Pharmaceuticals (ACRX). Who are Diurnal Group's key executives? Diurnal Group's management team includes the following people: Dr. Martin Whitaker B.Sc., BSc, Ph.D., CEO & Exec. DirectorMr. Richard Edward Bungay BSc, ACA, CFO,Director & Company Sec. (Age 50)Prof. Richard Ross, Chief Scientific Officer & Exec. DirectorMr. Michael Withe, Commercial DirectorMr. John Porter, Medical Director What is Diurnal Group's stock symbol? Diurnal Group trades on the London Stock Exchange (LON) under the ticker symbol "DNL." How do I buy shares of Diurnal Group? Shares of DNL and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock. What is Diurnal Group's stock price today? One share of DNL stock can currently be purchased for approximately GBX 30. How big of a company is Diurnal Group? Diurnal Group has a market capitalization of £36.49 million and generates £2.01 million in revenue each year. Diurnal Group employs 23 workers across the globe. What is Diurnal Group's official website? The official website for Diurnal Group is www.diurnal.co.uk. How can I contact Diurnal Group? Diurnal Group's mailing address is Heath Park, CARDIFF, CF14 4UJ, United Kingdom. The company can be reached via phone at +44-29-20682069. This page was last updated on 7/7/2020 by MarketBeat.com Staff 30 Days of MarketBeat All Access for $1.00 Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your Risk-Free Trial Subscription Here Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings
